science

House bill to remove cannabis from schedule list

Posted on March 2nd, 2017 by Global Ganja Report and tagged , , , , , , , .

capitolRep. Tom Garrett (R-VA) on Feb. 27 announced the introduction of legislation aimed at decriminalizing cannabis at the federal level. The ambitiously named "Ending Federal Marijuana Prohibition Act of 2017" would actually take cannabis off the federal controlled substances list—leaving regulation up to the states, and essentually giving the herb the same status as alcohol and tobacco. The bill revives an effort frst launched in the Senate by Bernie Sanders in 2015.

'Synthetic marijuana' scare in New York

Posted on January 6th, 2017 by Bill Weinberg and tagged , , , , .

New York A rather sensationalistic piece in the New York Times last month luridly headlined: "Drug 85 Times as Potent as Marijuana Caused a 'Zombielike' State in Brooklyn." Apparently, emergency medical technicians called to a "mass casualty event" in Brooklyn's Bushwick neighborhood reported multiple people at the scene, "all of whom had a degree of altered mental status that was described by bystanders as 'zombielike,'" according to a study published in the New England Journal of Medicine. Blood and urine samples drawn from eight of the 18 men hospitalized that day revealed they had taken a synthetic cannabinoid called AMB-FUBINACA, originally developed by the pharmaceutical company Pfizer, with the street names "AK-47" or "24 Karat Gold." It is said to be 85 times as potent as the main agent in natural cannabis, THC, or tetrahydrocannabinol.

Martin Lee speaks on CBD in New York City

medical marijuanaA little New York-California cross-fertilization of herbal consciousness took place as Martin Lee, the author of Smoke Signals: A Social History of Marijuana, spoke in Manhattan's East Village the night of Nov. 10 on "The Future of CBD and Medicinal Cannabis." Lee discussed his current work with California-based Project CBD, dedicated to promoting and publicizing research into the medical uses of cannabidiol, and Emerald Pharms, his CBD-oriented dispensary in Hopland, southern Medocino County. The event was hosted by The Alchemist's Kitchen, a New Age-flavored herbal apothecary—or "botanical dispensary"—on East 1st Street. Under New York state's medical marijuana law, the Kitchen recently launched a Bowery Cannabis Club, which specializes in CBD products.

UK government acknowledges medical value of cannabinoid

Posted on October 13th, 2016 by Global Ganja Report and tagged , , , , , , , .

medical marijuana The British government's Medicines & Healthcare Regulatory Agency (MHRA) on Oct. 11 issued a finding that cannabidiol (CBD) has a "restoring, correcting or modifying" effect on "physiological functions." The Independent calls the move "a potential milestone in the campaign to legalise cannabis and bring about evidence-based laws regarding drugs."  The review of CBD, a non-psychoactive cannabinoid increasingly studied for its therapeutic value, was undertaken following discussions with MediPen, a London-based company that seeks to market a CBD vaporizer.

Cops to get 'potalyzers' for roadside marijuana tests

Posted on September 12th, 2016 by Bill Weinberg and tagged , , , , , .

Shadow WatchResearchers at Stanford University have developed a "potalyzer"—a device that can detect human THC levels, so cops can determine if a motorist is too impaired to drive. The hand-held device uses sophisticated bio-sensors to detect THC molecules in saliva. Police officers will supposedly be able collect a spit sample with a cotton swab and read the results on a smartphone or laptop in just three minutes.

DEA turns down bid to reschedule cannabis

Posted on August 13th, 2016 by Bill Weinberg and tagged , , , , , .

THC After much speculation that the US Drug Enforcement Agency (DEA) would reschedule cannabis this summer, the agency on Aug. 11 dashed petitioners' hopes, rejecting their request to remove its classification as a Schedule I dangerous drug. The DEA denied two separate requests by former state governors to re-classify cannabis as a Schedule II drug or lower. The agency stated (PDF) that the Department of Health and Human Services (HHS) has "concluded that marijuana has high potential for abuse, has no accepted medical use in the United States, and lacks an acceptable level of safety for use even under medical supervision." Tthe DEA did propose a new policy that would allow universities to apply to grow cannabis for research. Until now, the University of Mississippi had a monopoly on cultivation for study. (Jurist)

Contention over THC maximum proposals in Canada, Colorado

Posted on July 10th, 2016 by Global Ganja Report and tagged , , , , , , , .

CanadaAs Canada prepares to legalize cannabis nationwide, Ottawa is consulting citizens and stake-holders to shape the new policy. Among the proposals floated at a Vancouver Cannabis Hemp Conference this weekend was a measure to cap the THC content of approved strains. Not surprisingly, this met with a resounding negative from industry and advocates. "It's time for us to stop demonizing THC. We need policy that's based on both evidence and expertise," Hilary Black of the BC Compassion Club Society told the CBC.  "We have an opportunity in Canada right now to be leaders on the world stage and to do this right."

DEA to re-schedule cannabis this summer: reports

Posted on June 20th, 2016 by Bill Weinberg and tagged , , , , , .

THCThe Internet is atwitter over a June 19 report in the Santa Monica Observer with the headline: "US Gov't Will Legalize Marijuana on August 1." The article claims that "weed will soon be legal in all 50 states, with a prescription," thanks to the imminent government action, with cannabis about to be switched from Schedule I to Schedule II. An unnamed DEA attorney is quoted as saying: "Whatever the law may be in California, Arizona or Utah or any other State, because of Federal preemption this will have the effect of making THC products legal with a prescription, in all 50 states." The story also cites a June 17 article in the Denver Post asserting (with no attribution) that the DEA will issue a decision in the matter by July 1.

Who's new

  • Baba Israel
  • Karr Young
  • John Veit
  • YosephLeib
  • Peter Gorman